Saudi crude exports from the Red Sea are increasingly vanishing from view as tankers switch off tracking signals to avoid attacks by Yemen’s Iran-aligned Houthis, according to ship-tracking firms and industry analysts. The shift obscures visibility into global oil supply assessments and creates wide discrepancies in export estimates used by the International Energy Agency and … Read more
Sanofi is experiencing active shortages of Myozyme and Nexviazyme, two critical enzyme replacement therapies used to treat Pompe disease, according to reporting by STAT. The supply chain disruption emerged shortly after the U.S. Food and Drug Administration issued a warning letter to the drugmaker regarding manufacturing issues at its Irish production facility in Waterford. Manufacturing … Read more
Eli Lilly Expands Early Access to Retatrutide Following Patient Advocacy Eli Lilly has confirmed it will allow a broader range of patients to apply for early access to its unapproved obesity drug, retatrutide. The decision follows a report by STAT regarding a 79-year-old patient who previously received special access to the medication. The pharmaceutical company … Read more
The U.S. pharmaceutical supply chain is facing mounting pressure as active medication shortages climbed to 227 in the second quarter of 2026, up from 214 in the third quarter of 2025. According to data from the American Society of Health-System Pharmacists (ASHP), these shortages increasingly involve sole-source products and critical diagnostic tools, signaling a systemic … Read more
The National Institutes of Health (NIH) “All of Us” research program is working to acquire electronic health records for more than 300,000 participants to address critical data gaps. By using patient data-sharing networks, the program aims to complete its precision medicine database, which has collected information from nearly 750,000 people since 2018. Why is the … Read more
Leadership Vacuum at the NIH: What Stability Means for Global Health Security The revolving door at the National Institutes of Health (NIH) has turned once again. With the recent departure of Jeffery Taubenberger, the acting head of the National Institute of Allergy and Infectious Diseases (NIAID), the scientific community is left grappling with questions about … Read more
Health Tech Correspondent Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth and digital therapeutics. His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech … Read more
The Shifting Landscape of Pharmacy Benefit Managers: Accountability and Transparency on the Horizon For years, concerns have mounted regarding the role of pharmacy benefit managers (PBMs) in the prescription drug supply chain. Accusations of prioritizing profits over patient access and affordability have been widespread. Now, a confluence of Congressional action and Department of Labor (DOL) … Read more
AI-Powered Drug Discovery: Lilly and Insilico Medicine Forge a $2.75 Billion Partnership The pharmaceutical landscape is undergoing a seismic shift, driven by the integration of artificial intelligence (AI) into drug discovery. A recent collaboration between Eli Lilly and Insilico Medicine, valued at up to $2.75 billion, exemplifies this trend. The deal, announced on March 29, … Read more
Novo Nordisk’s Strategic Shift: Candy Executive Joins Board as Obesity Market Heats Up Novo Nordisk, a leading pharmaceutical company, is bolstering its consumer focus with a surprising appointment: Poul Weihrauch, CEO of Mars, the candy company, as a board observer. This move signals a strategic pivot as Novo Nordisk aims to strengthen its position in … Read more